Clinical Trials Directory

Trials / Conditions / Stage IV Endometrial Carcinoma

Stage IV Endometrial Carcinoma

9 registered clinical trials studyying Stage IV Endometrial Carcinoma.

StatusTrialSponsorPhase
TerminatedLymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery
NCT01939028
Case Comprehensive Cancer CenterN/A
CompletedGamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanc
NCT01198184
National Cancer Institute (NCI)Phase 1
CompletedTemsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors
NCT01155258
University of Southern CaliforniaPhase 1
CompletedStereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignan
NCT01079832
Case Comprehensive Cancer CenterPhase 2
CompletedTemsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors
NCT00408655
National Cancer Institute (NCI)Phase 1
CompletedIxabepilone in Treating Patients With Recurrent or Persistent Endometrial Cancer
NCT00095979
National Cancer Institute (NCI)Phase 2
CompletedEF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometria
NCT00107445
National Cancer Institute (NCI)Phase 2
Completed7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid
NCT00031681
National Cancer Institute (NCI)Phase 1
CompletedInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
NCT00004074
National Cancer Institute (NCI)Phase 1